162 related articles for article (PubMed ID: 8220923)
1. Reactive arthritis associated with Bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: a report of two cases.
Jawad AS; Kahn L; Copland RF; Henderson DC; Abdul-Ahad AK
Br J Rheumatol; 1993 Nov; 32(11):1018-20. PubMed ID: 8220923
[No Abstract] [Full Text] [Related]
2. Reactive arthritis after the intravesical instillation of BCG.
Macía Villa C; Sifuentes Giraldo W; Boteanu A; González Lanza M; Bachiller Corral J
Reumatol Clin; 2012; 8(5):284-6. PubMed ID: 22377450
[TBL] [Abstract][Full Text] [Related]
3. Reiter's syndrome after intravesical Bacillus Calmette-Guérin treatment for superficial bladder carcinoma.
Pancaldi P; Van Linthoudt D; Alborino D; Haefliger JM; Ott H
Br J Rheumatol; 1993 Dec; 32(12):1096-8. PubMed ID: 8252321
[TBL] [Abstract][Full Text] [Related]
4. Reactive arthritis associated with bacillus Calmette-Guérin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens.
Miossec P
J Rheumatol; 1996 Aug; 23(8):1485. PubMed ID: 8856640
[No Abstract] [Full Text] [Related]
5. Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer.
Sosnowski JT
Compr Ther; 1994; 20(12):695-701. PubMed ID: 7882653
[No Abstract] [Full Text] [Related]
6. Reactive arthritis following BCG immunotherapy for bladder carcinoma.
Tinazzi E; Ficarra V; Simeoni S; Peterlana D; Lunardi C
Clin Rheumatol; 2005 Aug; 24(4):425-7. PubMed ID: 15660288
[TBL] [Abstract][Full Text] [Related]
7. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].
Shiba M; Fujii T; Takatera H
Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604
[TBL] [Abstract][Full Text] [Related]
8. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy.
Dudelzak J; Curtis AR; Sheehan DJ; Lesher JL
J Drugs Dermatol; 2008 Jul; 7(7):684. PubMed ID: 18664162
[No Abstract] [Full Text] [Related]
9. The preparation, handling and use of intravesical bacillus Calmette-Guerin for the management of stage Ta, T1, carcinoma in situ and transitional cell cancer.
Brosman SA; Lamm DL
J Urol; 1990 Aug; 144(2 Pt 1):313-5. PubMed ID: 2374197
[TBL] [Abstract][Full Text] [Related]
10. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
[TBL] [Abstract][Full Text] [Related]
11. Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall.
Böhle A; Gerdes J; Ulmer AJ; Hofstetter AG; Flad HD
J Urol; 1990 Jul; 144(1):53-8. PubMed ID: 2359181
[TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guérin immunotherapy. Techniques and results.
Brosman SA
Urol Clin North Am; 1992 Aug; 19(3):557-64. PubMed ID: 1636239
[TBL] [Abstract][Full Text] [Related]
13. [Dactilitis and oligoarthritis after BCG immunotherapy in a patient affected by bladder cancer].
Manzini CU; Bernini L; Elkhaldi N; Mascia MT; Ferri C
Reumatismo; 2006; 58(3):230-2. PubMed ID: 17013441
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer immunotherapy.
Lamm DL; Thor DE; Stogdill VD; Radwin HM
J Urol; 1982 Nov; 128(5):931-5. PubMed ID: 6757467
[TBL] [Abstract][Full Text] [Related]
15. Predicting bacillus Calmette-Guerin immunotherapy effectiveness.
Griffith TS
J Urol; 2007 Dec; 178(6):2247-8. PubMed ID: 17936825
[No Abstract] [Full Text] [Related]
16. Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer.
Sarosdy MF; Lamm DL
J Urol; 1989 Sep; 142(3):719-22. PubMed ID: 2769847
[TBL] [Abstract][Full Text] [Related]
17. [Relapsing Reiter's syndrome after Bacillus Calmette-Guérin immunotherapy for bladder carcinoma].
Pego JM; Lamas C; Hernández I; Suso J
Med Clin (Barc); 2003 Sep; 121(9):356-7. PubMed ID: 14499076
[No Abstract] [Full Text] [Related]
18. Severe uveitis followed by reactive arthritis after bacillus Calmette-Guérin therapy.
Chevrel G; Zech C; Miossec P
J Rheumatol; 1999 Apr; 26(4):1011. PubMed ID: 10229442
[No Abstract] [Full Text] [Related]
19. Reiter's syndrome following intravesical BCG immunotherapy.
Hogarth MB; Thomas S; Seifert MH; Tariq SM
Postgrad Med J; 2000 Dec; 76(902):791-3. PubMed ID: 11085772
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guerin immunotherapy for bladder cancer.
Lamm DL
J Urol; 1985 Jul; 134(1):40-7. PubMed ID: 3892050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
